2006
DOI: 10.1002/hep.21082
|View full text |Cite
|
Sign up to set email alerts
|

Zonal gene expression in murine liver: Lessons from tumors

Abstract: Gene expression in hepatocytes within the liver lobule is differentially regulated along the portal to central axis; however, the mechanisms governing the processes of zonation within the lobule are unknown. A model for zonal heterogeneity in normal liver is proposed, based on observations of differential expression of genes in liver tumors from mice that harbor activating mutations in either Catnb (which codes for ␤-catenin) or Ha-ras. According to the model, the regulatory control consists of two opposing si… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

5
156
3
2

Year Published

2006
2006
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 133 publications
(166 citation statements)
references
References 35 publications
5
156
3
2
Order By: Relevance
“…Simultaneous mutation of the β-catenin gene and the tumour suppressor H-ras or p21 by an adenovirus-mediated liver-specific Cre-expression system resulted in 100% tumour incidence with short latency of only several weeks (65). Interestingly, mutations in the β-catenin gene in hepatocellular carcinomas induce overexpression of β-catenin targets such as the glutamine synthetase gene GLUL (66,67), whereas hepatocytes from glutamine synthetase-negative tumours are often H-ras or BRAF mutated and express E-cadherin, reflecting perivenous and periportal profiles, respectively (68). Loss-of-function in APC and Axin is mutually exclusive to CTNNB1 mutations and has been detected in 1-3% and 8-15% of hepatocellular carcinoma cases (for review, see (69)).…”
Section: Wnt/β-catenin Signalling and Cancermentioning
confidence: 99%
“…Simultaneous mutation of the β-catenin gene and the tumour suppressor H-ras or p21 by an adenovirus-mediated liver-specific Cre-expression system resulted in 100% tumour incidence with short latency of only several weeks (65). Interestingly, mutations in the β-catenin gene in hepatocellular carcinomas induce overexpression of β-catenin targets such as the glutamine synthetase gene GLUL (66,67), whereas hepatocytes from glutamine synthetase-negative tumours are often H-ras or BRAF mutated and express E-cadherin, reflecting perivenous and periportal profiles, respectively (68). Loss-of-function in APC and Axin is mutually exclusive to CTNNB1 mutations and has been detected in 1-3% and 8-15% of hepatocellular carcinoma cases (for review, see (69)).…”
Section: Wnt/β-catenin Signalling and Cancermentioning
confidence: 99%
“…7 This is also consistent with the early observation that cultured GS-positive hepatocytes maintain their phenotype throughout their lifespan in vitro despite cultivation in media mimicking periportal conditions. 8 The evidence provided by Hailfinger et al 1 concerning periportal signals is less clear. Firstly, the proposed influence of Ras activation was not demonstrated in vitro.…”
mentioning
confidence: 98%
“…The first of these would involve soluble factors from the bloodstream inducing Ras activation prevailing in the periportal zone, while the second would consist of an inverse gradient of Wnt signals inducing activation of ␤-catenin prevailing in the pericentral zone. Although this hypothesis is attractive for a number of reasons, the experimental evidence provided by Hailfinger et al 1 does not in itself constitute substantial support.Recent observations have left no doubt that expression of glutamine synthetase (GS), the most pronounced marker enzyme of pericentral cells, 2 is somehow dependent on ␤-catenin signaling. [3][4][5] However, although activation of ␤-catenin seems necessary, it does not appear to be sufficient, since many liver tumors with activated ␤-catenin do not express GS.…”
mentioning
confidence: 99%
See 2 more Smart Citations